Skip to main content
Top
Published in: Diabetologia 4/2010

01-04-2010 | Article

Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCα and PKCδ

Authors: Y. Z. De Marinis, E. Zhang, S. Amisten, J. Taneera, E. Renström, P. Rorsman, L. Eliasson

Published in: Diabetologia | Issue 4/2010

Login to get access

Abstract

Aims/hypothesis

Protein kinase C (PKC) regulates exocytosis in various secretory cells. Here we studied intracellular translocation of the PKC isoenzymes PKCα and PKCδ, and investigated how activation of PKC influences glucagon secretion in mouse and human pancreatic alpha cells.

Methods

Glucagon release from intact islets was measured in static incubations, and the amounts released were determined by RIA. Exocytosis was monitored as increases in membrane capacitance using the patch-clamp technique. The expression of genes encoding PKC isoforms was analysed by real-time PCR. Intracellular PKC distribution was assessed by confocal microscopy.

Results

The PKC activator phorbol 12-myristate 13-acetate (PMA) stimulated glucagon secretion from mouse and human islets about fivefold (p < 0.01). This stimulation was abolished by the PKC inhibitor bisindolylmaleimide (BIM). Whereas PMA potentiated exocytosis more than threefold (p < 0.001), BIM inhibited alpha cell exocytosis by 60% (p < 0.05). In mouse islets, the PKC isoenzymes, PKCα and PKCβ1, were highly abundant, while in human islets PKCη, PKCε and PKCζ were the dominant variants. PMA stimulation of human alpha cells correlated with the translocation of PKCα and PKCδ from the cytosol to the cell periphery. In the mouse alpha cells, PKCδ was similarly affected by PMA, whereas PKCα was already present at the cell membrane in the absence of PMA. This association of PKCα in alpha cells was principally dependent on Ca2+ influx through the L-type Ca2+ channel.

Conclusions/interpretation

PKC activation augments glucagon secretion in mouse and human alpha cells. This effect involves translocation of PKCα and PKCδ to the plasma membrane, culminating in increased Ca2+-dependent exocytosis. In addition, we demonstrated that PKCα translocation and exocytosis exhibit differential Ca2+ channel dependence.
Literature
1.
go back to reference Lins PE, Wajngot A, Adamson U, Vranic M, Efendic S (1983) Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Diabetes 32:633–636CrossRefPubMed Lins PE, Wajngot A, Adamson U, Vranic M, Efendic S (1983) Minimal increases in glucagon levels enhance glucose production in man with partial hypoinsulinemia. Diabetes 32:633–636CrossRefPubMed
2.
go back to reference Myers SR, Diamond MP, Adkins-Marshall BA, Williams PE, Stinsen R, Cherrington AD (1991) Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. Metabolism 40:66–71CrossRefPubMed Myers SR, Diamond MP, Adkins-Marshall BA, Williams PE, Stinsen R, Cherrington AD (1991) Effects of small changes in glucagon on glucose production during a euglycemic, hyperinsulinemic clamp. Metabolism 40:66–71CrossRefPubMed
3.
go back to reference Cryer PE (2004) Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272–2279CrossRefPubMed Cryer PE (2004) Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272–2279CrossRefPubMed
4.
go back to reference Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA (2000) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85:4053–4059CrossRefPubMed Shah P, Vella A, Basu A, Basu R, Schwenk WF, Rizza RA (2000) Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 85:4053–4059CrossRefPubMed
5.
go back to reference Gromada J, Franklin I, Wollheim CB (2007) Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84–116CrossRefPubMed Gromada J, Franklin I, Wollheim CB (2007) Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28:84–116CrossRefPubMed
6.
go back to reference Gromada J, Bokvist K, Ding WG et al (1997) Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol 110:217–228CrossRefPubMed Gromada J, Bokvist K, Ding WG et al (1997) Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol 110:217–228CrossRefPubMed
7.
go back to reference Vieira E, Liu YJ, Gylfe E (2004) Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn Schmiedebergs Arch Pharmacol 369:179–183CrossRefPubMed Vieira E, Liu YJ, Gylfe E (2004) Involvement of alpha1 and beta-adrenoceptors in adrenaline stimulation of the glucagon-secreting mouse alpha-cell. Naunyn Schmiedebergs Arch Pharmacol 369:179–183CrossRefPubMed
8.
go back to reference Dunning BE, Foley JE, Ahren B (2005) Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48:1700–1713CrossRefPubMed Dunning BE, Foley JE, Ahren B (2005) Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48:1700–1713CrossRefPubMed
9.
go back to reference Gromada J, Hoy M, Buschard K, Salehi A, Rorsman P (2001) Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol 535:519–532CrossRefPubMed Gromada J, Hoy M, Buschard K, Salehi A, Rorsman P (2001) Somatostatin inhibits exocytosis in rat pancreatic alpha-cells by G(i2)-dependent activation of calcineurin and depriming of secretory granules. J Physiol 535:519–532CrossRefPubMed
10.
go back to reference Ma X, Zhang Y, Gromada J et al (2005) Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors. Mol Endocrinol 19:198–212CrossRefPubMed Ma X, Zhang Y, Gromada J et al (2005) Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors. Mol Endocrinol 19:198–212CrossRefPubMed
11.
go back to reference Gopel S, Zhang Q, Eliasson L et al (2004) Capacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans. J Physiol 556:711–726CrossRefPubMed Gopel S, Zhang Q, Eliasson L et al (2004) Capacitance measurements of exocytosis in mouse pancreatic alpha-, beta- and delta-cells within intact islets of Langerhans. J Physiol 556:711–726CrossRefPubMed
12.
go back to reference Rorsman P, Hellman B (1988) Voltage-activated currents in guinea pig pancreatic alpha 2 cells. Evidence for Ca2+-dependent action potentials. J Gen Physiol 91:223–242CrossRefPubMed Rorsman P, Hellman B (1988) Voltage-activated currents in guinea pig pancreatic alpha 2 cells. Evidence for Ca2+-dependent action potentials. J Gen Physiol 91:223–242CrossRefPubMed
13.
go back to reference Barg S, Galvanovskis J, Gopel SO, Rorsman P, Eliasson L (2000) Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 49:1500–1510CrossRefPubMed Barg S, Galvanovskis J, Gopel SO, Rorsman P, Eliasson L (2000) Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 49:1500–1510CrossRefPubMed
14.
go back to reference MacDonald PE, De Marinis YZ, Ramracheya R et al (2007) A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 5:e143CrossRefPubMed MacDonald PE, De Marinis YZ, Ramracheya R et al (2007) A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans. PLoS Biol 5:e143CrossRefPubMed
15.
go back to reference Hii CS, Stutchfield J, Howell SL (1986) Enhancement of glucagon secretion from isolated rat islets of Langerhans by phorbol 12-myristate 13-acetate. Biochem J 233:287–289PubMed Hii CS, Stutchfield J, Howell SL (1986) Enhancement of glucagon secretion from isolated rat islets of Langerhans by phorbol 12-myristate 13-acetate. Biochem J 233:287–289PubMed
16.
go back to reference Bjaaland T, Hii CS, Jones PM, Howell SL (1988) Role of protein kinase C in arginine-induced glucagon secretion from isolated rat islets of Langerhans. J Mol Endocrinol 1:105–110CrossRefPubMed Bjaaland T, Hii CS, Jones PM, Howell SL (1988) Role of protein kinase C in arginine-induced glucagon secretion from isolated rat islets of Langerhans. J Mol Endocrinol 1:105–110CrossRefPubMed
17.
go back to reference Shirai Y, Saito N (2002) Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem 132:663–668PubMed Shirai Y, Saito N (2002) Activation mechanisms of protein kinase C: maturation, catalytic activation, and targeting. J Biochem 132:663–668PubMed
18.
go back to reference Wolf BA, Easom RA, Hughes JH, McDaniel ML, Turk J (1989) Secretagogue-induced diacylglycerol accumulation in isolated pancreatic islets. Mass spectrometric characterization of the fatty acyl content indicates multiple mechanisms of generation. Biochemistry 28:4291–4301CrossRefPubMed Wolf BA, Easom RA, Hughes JH, McDaniel ML, Turk J (1989) Secretagogue-induced diacylglycerol accumulation in isolated pancreatic islets. Mass spectrometric characterization of the fatty acyl content indicates multiple mechanisms of generation. Biochemistry 28:4291–4301CrossRefPubMed
19.
go back to reference Malaisse WJ, Dunlop ME, Mathias PC, Malaisse-Lagae F, Sener A (1985) Stimulation of protein kinase C and insulin release by 1-oleoyl-2-acetyl-glycerol. Eur J Biochem 149:23–27CrossRefPubMed Malaisse WJ, Dunlop ME, Mathias PC, Malaisse-Lagae F, Sener A (1985) Stimulation of protein kinase C and insulin release by 1-oleoyl-2-acetyl-glycerol. Eur J Biochem 149:23–27CrossRefPubMed
20.
go back to reference Zawalich W, Brown C, Rasmussen H (1983) Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun 117:448–455CrossRefPubMed Zawalich W, Brown C, Rasmussen H (1983) Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun 117:448–455CrossRefPubMed
21.
go back to reference Stutchfield J, Jones PM, Howell SL (1986) The effects of polymyxin B, a protein kinase C inhibitor, on insulin secretion from intact and permeabilized islets of Langerhans. Biochem Biophys Res Commun 136:1001–1006CrossRefPubMed Stutchfield J, Jones PM, Howell SL (1986) The effects of polymyxin B, a protein kinase C inhibitor, on insulin secretion from intact and permeabilized islets of Langerhans. Biochem Biophys Res Commun 136:1001–1006CrossRefPubMed
22.
go back to reference Easom RA, Hughes JH, Landt M, Wolf BA, Turk J, McDaniel ML (1989) Comparison of effects of phorbol esters and glucose on protein kinase C activation and insulin secretion in pancreatic islets. Biochem J 264:27–33PubMed Easom RA, Hughes JH, Landt M, Wolf BA, Turk J, McDaniel ML (1989) Comparison of effects of phorbol esters and glucose on protein kinase C activation and insulin secretion in pancreatic islets. Biochem J 264:27–33PubMed
23.
go back to reference Hille B, Billiard J, Babcock DF, Nguyen T, Koh DS (1999) Stimulation of exocytosis without a calcium signal. J Physiol 520(Pt 1):23–31CrossRefPubMed Hille B, Billiard J, Babcock DF, Nguyen T, Koh DS (1999) Stimulation of exocytosis without a calcium signal. J Physiol 520(Pt 1):23–31CrossRefPubMed
24.
go back to reference Turner KM, Burgoyne RD, Morgan A (1999) Protein phosphorylation and the regulation of synaptic membrane traffic. Trends Neurosci 22:459–464CrossRefPubMed Turner KM, Burgoyne RD, Morgan A (1999) Protein phosphorylation and the regulation of synaptic membrane traffic. Trends Neurosci 22:459–464CrossRefPubMed
25.
go back to reference Leenders AG, Sheng ZH (2005) Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol Ther 105:69–84CrossRefPubMed Leenders AG, Sheng ZH (2005) Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol Ther 105:69–84CrossRefPubMed
26.
go back to reference Hoy M, Berggren PO, Gromada J (2003) Involvement of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis in mouse pancreatic beta-cells. J Biol Chem 278:35168–35171CrossRefPubMed Hoy M, Berggren PO, Gromada J (2003) Involvement of protein kinase C-epsilon in inositol hexakisphosphate-induced exocytosis in mouse pancreatic beta-cells. J Biol Chem 278:35168–35171CrossRefPubMed
27.
go back to reference Ganesan S, Calle R, Zawalich K et al (1992) Immunocytochemical localization of alpha-protein kinase C in rat pancreatic beta-cells during glucose-induced insulin secretion. J Cell Biol 119:313–324CrossRefPubMed Ganesan S, Calle R, Zawalich K et al (1992) Immunocytochemical localization of alpha-protein kinase C in rat pancreatic beta-cells during glucose-induced insulin secretion. J Cell Biol 119:313–324CrossRefPubMed
28.
go back to reference Uchida T, Iwashita N, Ohara-Imaizumi M et al (2007) Protein kinase Cdelta plays a non-redundant role in insulin secretion in pancreatic beta cells. J Biol Chem 282:2707–2716CrossRefPubMed Uchida T, Iwashita N, Ohara-Imaizumi M et al (2007) Protein kinase Cdelta plays a non-redundant role in insulin secretion in pancreatic beta cells. J Biol Chem 282:2707–2716CrossRefPubMed
29.
go back to reference Yedovitzky M, Mochly-Rosen D, Johnson JA et al (1997) Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J Biol Chem 272:1417–1420CrossRefPubMed Yedovitzky M, Mochly-Rosen D, Johnson JA et al (1997) Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J Biol Chem 272:1417–1420CrossRefPubMed
30.
go back to reference Toonen RF, Verhage M (2007) Munc18-1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci 30:564–572PubMed Toonen RF, Verhage M (2007) Munc18-1 in secretion: lonely Munc joins SNARE team and takes control. Trends Neurosci 30:564–572PubMed
31.
go back to reference Craig TJ, Evans GJ, Morgan A (2003) Physiological regulation of Munc18/nSec1 phosphorylation on serine-313. J Neurochem 86:1450–1457CrossRefPubMed Craig TJ, Evans GJ, Morgan A (2003) Physiological regulation of Munc18/nSec1 phosphorylation on serine-313. J Neurochem 86:1450–1457CrossRefPubMed
32.
go back to reference Barclay JW, Craig TJ, Fisher RJ et al (2003) Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis. J Biol Chem 278:10538–10545CrossRefPubMed Barclay JW, Craig TJ, Fisher RJ et al (2003) Phosphorylation of Munc18 by protein kinase C regulates the kinetics of exocytosis. J Biol Chem 278:10538–10545CrossRefPubMed
33.
go back to reference Amisten S, Braun OO, Bengtsson A, Erlinge D (2008) Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb Res 122:47–57CrossRefPubMed Amisten S, Braun OO, Bengtsson A, Erlinge D (2008) Gene expression profiling for the identification of G-protein coupled receptors in human platelets. Thromb Res 122:47–57CrossRefPubMed
34.
go back to reference Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45CrossRefPubMed Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45CrossRefPubMed
35.
go back to reference Salehi A, Vieira E, Gylfe E (2006) Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes 55:2318–2323CrossRefPubMed Salehi A, Vieira E, Gylfe E (2006) Paradoxical stimulation of glucagon secretion by high glucose concentrations. Diabetes 55:2318–2323CrossRefPubMed
36.
go back to reference Gillis KD, Mossner R, Neher E (1996) Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16:1209–1220CrossRefPubMed Gillis KD, Mossner R, Neher E (1996) Protein kinase C enhances exocytosis from chromaffin cells by increasing the size of the readily releasable pool of secretory granules. Neuron 16:1209–1220CrossRefPubMed
37.
go back to reference Mendez CF, Leibiger IB, Leibiger B et al (2003) Rapid association of protein kinase C-epsilon with insulin granules is essential for insulin exocytosis. J Biol Chem 278:44753–44757CrossRefPubMed Mendez CF, Leibiger IB, Leibiger B et al (2003) Rapid association of protein kinase C-epsilon with insulin granules is essential for insulin exocytosis. J Biol Chem 278:44753–44757CrossRefPubMed
38.
go back to reference Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693–698CrossRefPubMed Nishizuka Y (1984) The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308:693–698CrossRefPubMed
39.
go back to reference Ammala C, Eliasson L, Bokvist K et al (1994) Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci USA 91:4343–4347CrossRefPubMed Ammala C, Eliasson L, Bokvist K et al (1994) Activation of protein kinases and inhibition of protein phosphatases play a central role in the regulation of exocytosis in mouse pancreatic beta cells. Proc Natl Acad Sci USA 91:4343–4347CrossRefPubMed
40.
go back to reference Lindau M, Gomperts BD (1991) Techniques and concepts in exocytosis: focus on mast cells. Biochim Biophys Acta 1071:429–471PubMed Lindau M, Gomperts BD (1991) Techniques and concepts in exocytosis: focus on mast cells. Biochim Biophys Acta 1071:429–471PubMed
41.
go back to reference Nili U, de Wit H, Gulyas-Kovacs A et al (2006) Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells. Neuroscience 143:487–500CrossRefPubMed Nili U, de Wit H, Gulyas-Kovacs A et al (2006) Munc18-1 phosphorylation by protein kinase C potentiates vesicle pool replenishment in bovine chromaffin cells. Neuroscience 143:487–500CrossRefPubMed
42.
go back to reference Toullec D, Pianetti P, Coste H et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771–15781PubMed Toullec D, Pianetti P, Coste H et al (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771–15781PubMed
43.
go back to reference Park WS, Son YK, Ko EA et al (2005) The protein kinase C inhibitor, bisindolylmaleimide (I), inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. Life Sci 77:512–527CrossRefPubMed Park WS, Son YK, Ko EA et al (2005) The protein kinase C inhibitor, bisindolylmaleimide (I), inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells. Life Sci 77:512–527CrossRefPubMed
44.
go back to reference Kim A, Bae YM, Kim J et al (2004) Direct block by bisindolylmaleimide of the voltage-dependent K+ currents of rat mesenteric arterial smooth muscle. Eur J Pharmacol 483:117–126CrossRefPubMed Kim A, Bae YM, Kim J et al (2004) Direct block by bisindolylmaleimide of the voltage-dependent K+ currents of rat mesenteric arterial smooth muscle. Eur J Pharmacol 483:117–126CrossRefPubMed
45.
go back to reference Kraft AS, Anderson WB (1983) Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature 301:621–623CrossRefPubMed Kraft AS, Anderson WB (1983) Phorbol esters increase the amount of Ca2+, phospholipid-dependent protein kinase associated with plasma membrane. Nature 301:621–623CrossRefPubMed
46.
go back to reference Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332(Pt 2):281–292PubMed Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332(Pt 2):281–292PubMed
47.
go back to reference Quesada I, Todorova MG, Alonso-Magdalena P et al (2006) Glucose induces opposite intracellular Ca2+ concentration oscillatory patterns in identified alpha- and beta-cells within intact human islets of Langerhans. Diabetes 55:2463–2469CrossRefPubMed Quesada I, Todorova MG, Alonso-Magdalena P et al (2006) Glucose induces opposite intracellular Ca2+ concentration oscillatory patterns in identified alpha- and beta-cells within intact human islets of Langerhans. Diabetes 55:2463–2469CrossRefPubMed
48.
go back to reference Nadal A, Quesada I, Soria B (1999) Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse. J Physiol 517(Pt 1):85–93CrossRefPubMed Nadal A, Quesada I, Soria B (1999) Homologous and heterologous asynchronicity between identified alpha-, beta- and delta-cells within intact islets of Langerhans in the mouse. J Physiol 517(Pt 1):85–93CrossRefPubMed
49.
go back to reference Ali S, Drucker DJ (2009) Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am J Physiol Endocrinol Metab 296:E415–E421CrossRefPubMed Ali S, Drucker DJ (2009) Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes. Am J Physiol Endocrinol Metab 296:E415–E421CrossRefPubMed
Metadata
Title
Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCα and PKCδ
Authors
Y. Z. De Marinis
E. Zhang
S. Amisten
J. Taneera
E. Renström
P. Rorsman
L. Eliasson
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1635-x

Other articles of this Issue 4/2010

Diabetologia 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine